Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.LFWD · Entity 7620 | Director | August 01, 2025 | August 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date August 01, 2025 · Filed August 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 86,457 |
Reported balance
After 2025-08-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-08-01 · Grant · Acquired 71,839 · Balance 86,457 F1: Represents 71,839 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. |
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | Direct | 18,516 |
Reported balance
Holding disclosure · report date 2025-08-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 18,516 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 71,839 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NxStage Medical, Inc.
Report date February 21, 2019 · Filed February 25, 2019
Section 16 reporting ended · disclosed 2019-02-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 1
1 source rowRow 1 · 2019-02-21 · Disposition to issuer · Disposed 86,401 · Balance 0 F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.48 · Expires 2019-03-08 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-02-21 · Disposition to issuer · Disposed 7,542 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.03 · Expires 2023-03-03 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-02-21 · Disposition to issuer · Disposed 25,897 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.66 · Expires 2024-03-09 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-02-21 · Disposition to issuer · Disposed 36,958 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.66 · Expires 2025-03-02 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-02-21 · Disposition to issuer · Disposed 102,529 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.58 · Expires 2026-03-08 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-02-21 · Disposition to issuer · Disposed 178,772 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.89 · Expires 2027-03-08 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-02-21 · Disposition to issuer · Disposed 99,711 · Balance 0 F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2020-03-09 | Direct | 0 |
Reported balance
After 2019-02-21 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-02-21 · Disposition to issuer · Disposed 23,286 · Balance 0 F3: These performance shares were canceled in the Merger in exchange for an amount in cash equal to the product of the total number of performance shares multiplied by the Merger Consideration of $30 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of under Merger Agreement with Fresenius Medical Care Holdings, Inc. in which all outstanding shares of Issuer's Common Stock were converted into the right to receive $30 per share in cash.
F2: This option was canceled in the Merger in exchange for an amount in cash equal to the product of the total number of shares subject to the option multiplied by the excess of the Merger Consideration of $30 per share over the option exercise price.
F3: These performance shares were canceled in the Merger in exchange for an amount in cash equal to the product of the total number of performance shares multiplied by the Merger Consideration of $30 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2017 Filed Mar 13, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | GrantStock Option (Right to Buy) · Derivative | 99,711 | $0.00 Strike: $27.89 | $0.00 |
DisclosureSEC source: 0001246360-17-001319 · form.xml · derivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,711 Underlying: Common Stock · 99,711 shares Expires 2027-03-08 F1 · derivative.exercise_date: The stock option becomes exercisable in 48 equal monthly installments beginning April 9, 2017. Read SEC document |
| March 08, 2017 Filed Mar 8, 2017 18:42 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 1,000 | $27.53 | $27,530.00 |
DisclosureSEC source: 0001246360-17-001283 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,903 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 18:35 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionRestricted Stock Unit · Derivative | 9,747 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001208 · form.xml · derivative · entry 3 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,747 shares Expires 2017-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 18:35 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Tax withholdingCommon Stock | 3,163 | $28.31 | $89,544.53 |
DisclosureSEC source: 0001246360-17-001208 · form.xml · nonDerivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,903 Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 18:35 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 9,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001208 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 1, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,039 | $0.00 Strike: $9.96 | $0.00 |
DisclosureSEC source: 0001246360-17-001139 · form.xml · derivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,039 shares Expires 2017-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 1, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 5,039 | $9.96 | $50,188.44 |
DisclosureSEC source: 0001246360-17-001139 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,319 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 17:21 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $14.66 | $0.00 |
DisclosureSEC source: 0001246360-17-000885 · form.xml · derivative · entry 3 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,958 Underlying: Common Stock · 6,000 shares Expires 2024-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 17:21 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 6,000 | $29.66 | $177,960.00 |
DisclosureSEC source: 0001246360-17-000885 · form.xml · nonDerivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 17:21 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 6,000 | $14.66 | $87,960.00 |
DisclosureSEC source: 0001246360-17-000885 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $18.59 | $0.00 |
DisclosureSEC source: 0001246360-17-000586 · form.xml · derivative · entry 4 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Underlying: Common Stock · 2,500 shares Expires 2018-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 2,500 | $28.59 | $71,475.00 |
DisclosureSEC source: 0001246360-17-000586 · form.xml · nonDerivative · entry 3 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| February 10, 2017 Filed Feb 13, 2017 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 2,500 | $18.59 | $46,475.00 |
DisclosureSEC source: 0001246360-17-000586 · form.xml · nonDerivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 1,000 | $27.77 | $27,770.00 |
DisclosureSEC source: 0001246360-17-000586 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $14.66 | $0.00 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · derivative · entry 7 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,958 Underlying: Common Stock · 6,000 shares Expires 2024-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · derivative · entry 6 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,897 Underlying: Common Stock · 7,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,669 | $0.00 Strike: $18.48 | $0.00 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · derivative · entry 5 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,211 Underlying: Common Stock · 2,669 shares Expires 2019-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 15,669 | $26.19 | $410,371.11 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · nonDerivative · entry 4 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 6,000 | $14.66 | $87,960.00 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · nonDerivative · entry 3 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 7,000 | $11.03 | $77,210.00 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · nonDerivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 2, 2017 18:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 2,669 | $18.48 | $49,323.12 |
DisclosureSEC source: 0001246360-17-000416 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2017 Filed Jan 17, 2017 16:28 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 7,500 | $28.00 | $210,000.00 |
DisclosureSEC source: 0001246360-17-000181 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,280 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| January 11, 2017 Filed Jan 11, 2017 17:14 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 1,000 | $27.77 | $27,770.00 |
DisclosureSEC source: 0001246360-17-000169 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,780 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| December 13, 2016 Filed Dec 13, 2016 18:49 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 1,000 | $25.42 | $25,420.00 |
DisclosureSEC source: 0001246360-16-007450 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,780 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,669 | $0.00 Strike: $18.48 | $0.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · derivative · entry 9 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,880 Underlying: Common Stock · 2,669 shares Expires 2019-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 2,669 | $26.48 | $70,675.12 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 6 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,780 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 28, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 2,669 | $18.48 | $49,323.12 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 5 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $18.59 | $0.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · derivative · entry 8 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,723 Underlying: Common Stock · 2,500 shares Expires 2018-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $11.03 | $0.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · derivative · entry 7 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,897 Underlying: Common Stock · 7,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 7,000 | $26.03 | $182,210.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 4 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,780 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 2,500 | $25.44 | $63,600.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 3 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,780 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 2,500 | $18.59 | $46,475.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 2 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2016 Filed Nov 29, 2016 17:07 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | Exercise / conversionCommon Stock | 7,000 | $11.03 | $77,210.00 |
DisclosureSEC source: 0001246360-16-007244 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 17:00 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 1,000 | $25.97 | $25,970.00 |
DisclosureSEC source: 0001246360-16-007198 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,780 F1 · date: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. Read SEC document |
| November 16, 2016 Filed Nov 16, 2016 18:49 UTC | NxStage Medical, Inc. NXTM · Entity 159895 | SaleCommon Stock | 22,500 | $26.26 | $590,850.00 |
DisclosureSEC source: 0001246360-16-007183 · form.xml · nonDerivative · entry 1 Turk Joseph E Jr · CIK 0001341403 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,780 F1 · date: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016. F2 · shares: This represents the weighted average price for shares sold in multiple transactions at prices ranging from $26.16 to $26.59, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.